Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting

$CNMDPress releaseJul 20, 2026, 7:00 AM ETRead the release

CONMED is presenting data at the Society of Robotic Surgery Annual Meeting comparing its AirSeal system to Stryker's PneumoClear. The 40-patient trial demonstrated that AirSeal resulted in fewer nociceptive events (20.7 vs 33.5), shorter procedure times, and less blood loss.

Key figures

Trial sample size
40
P value blood loss
<0.001
P value nociception
0.041
P value console time
0.045
P value procedure time
0.045
Insufflation pressure mmhg
8
Nociceptive events airseal
20.7
Nociceptive events competitor
33.5

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    CNMD: CONMED Corporation to Participate in the Society of Robotic Surgery Annual Meeting — AI Analysis | Signal8